• Livzon Pharmaceutical Group agreed on Aug. 21, 2026 to buy a 3.5% stake in Xinbeijiang Pharma for RMB 106.7 million.
• Deal lifts its direct holding to about 90.64% from about 87.14%.
• Seller Zhong Hui Yuan is Xinbeijiang Pharma’s employee shareholding platform, making the purchase a connected transaction under Hong Kong rules.
• Pricing referenced Xinbeijiang Pharma net assets of RMB 3.04 billion as of Dec. 31, 2025.
• Payment due within five business days of completion, funded from internal resources.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Livzon Pharmaceutical Group Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294245), on August 21, 2026, and is solely responsible for the information contained therein.